Ronald N. Gaster, MD, FACS
19671 Beach Blvd., Suite 400
Huntington Beach, CA 92648
(855) 393-3622
Ronald N. Gaster, MD, FACS
50 N. La Cienega Blvd., Suite 340
Beverly Hills, CA 90211
(855) 393-3621
(310) 425-3938
Facebook

Corneal Crosslinking Expert - Dr. Ronald Gaster

Riboflavin Instillation Durinb CXLAs a leading ophthalmologist in Beverly Hills, California (CA) and Huntington Beach, California (CA), Dr. Ronald N. Gaster is on the cutting edge of developments in eye surgery and disease.

Dr. Gaster is currently a principal investigator in a clinical trial under an FDA protocol approved by the Western Institutional Review Board (WIRB) studying the overall efficacy of corneal cross-linking (CXL) to corneal cross-linking (CXL) plus Intacs for keratoconus or post-LASIK ectasia or pellucid marginal degeneration.



Corneal cross-linking uses riboflavin eye drops combined with ultraviolet light to stiffen and strengthen the corneal fibers and thus halt progression of the disease process.

Dr. Gaster has been an invited speaker nationally and internationally on Corneal Cross-Linking, presenting his results at numerous ophthalmology meetings. He was recently asked to discuss Corneal Cross-Linking and the surgery was videotaped and shown on the Emmy-award winning TV show, “The Doctors.”

Cornea Saturated with Riboflavin UV Light into the Cornea

Intacs Huntington Beach, Los AngelesCorneal cross-linking (CXL) is an investigational procedure for patients suffering from keratoconus or corneal ectasia that strengthens corneal fibers and can halt the progression of keratoconus.

Intacs are implantable intra-corneal ring segments (see photo) that can also benefit patients suffering from keratoconus or ectasia by flattening a steep cornea.

Dr. Gaster uses a Femtosecond Laser to create the channels for insertion of the Intacs segments.
 
 Both of these modalities are significantly more effective than orthokeratology or gas permeable hard contact lenses used to try to reshape the cornea. More importantly, by cross-linking early in the disease process, patients may avoid the need for corneal transplantation in the future.

Patients suffering from any of these conditions are encouraged to schedule a consultation with Dr. Ronald N. Gaster, ophthalmologist in Beverly Hills, California (CA) and Huntington Beach, California (CA), to discuss their eligibility. Dr. Gaster is passionate about the new, effective advancements in the treatment of a variety of ocular diseases and looks forward to improving the ocular health of his patients with these discoveries.

Dr. Gaster is interviewed by EyeWorld at the recent American Society of Cataract and Refractive Surgery meeting on Cross-Linking for Adolescents with Progressive Keratoconus